23<\/h2>\nPublicaciones<\/h2>\n\t\t\t\t![\"Hematopoietic-Stem-Cell-Biology-And-Leukemogenesis\"](\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2020\/05\/Hematopoietic-Stem-Cell-Biology-And-Leukemogenesis.png\" "\\"Hematopoietic-Stem-Cell-Biology-And-Leukemogenesis\\"")
\n\t\t\t\t\tL\u00edneas estrat\u00e9gicas<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tIdentificar v\u00edas de desarrollo involucradas en la generaci\u00f3n de c\u00e9lulas madre hematopoy\u00e9ticas para dirigir la diferenciaci\u00f3n de c\u00e9lulas madre pluripotenciales en c\u00e9lulas hematopoy\u00e9ticas cl\u00ednicamente relevantes<\/p>\n
Desarrollar modelos de desarrollo de c\u00e9lulas madre del c\u00e1ncer de sangre basados \u200b\u200ben c\u00e9lulas pluripotentes inducidas.<\/p>\n
Estos objetivos se realizar\u00e1n combinando gen\u00f3mica, transcript\u00f3mica, edici\u00f3n de genes y t\u00e9cnicas biol\u00f3gicas celulares.<\/p>\n
<\/p>\n\t\t\t\t\tPublicaciones seleccionadas<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t– Bigas A, Palma LG, Kartha GM, Giorgetti A. Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development.<\/strong> Stem Cells Transl. Med. 2022. doi: 10.1093\/stcltm\/szac071<\/p>\n– Kotmayer L, Romero Moya D, Marin Bejar O, Kozyra E, Catal\u00e0 A, Bigas A, Wlodarski MW, B\u00f6d\u00f6r C, Giorgetti A. GATA2 deficiency and MDS\/AML: Experimental strategies for disease modelling and future therapeutic prospects.<\/strong> Br J Haematol. 2022;199(4):482-495. doi:10.1111\/bjh.18330.<\/p>\n– Pera J, Casta\u00f1o J, Casamitjana J, Giorgetti A, Romero Moya D. Generation of heterozygous SAMD9 CRISPR\/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation<\/strong>. Stem Cell Res. 2022;64102906-102906. doi:10.1016\/j.scr.2022.102906. IF:1,59.<\/p>\n– Casta\u00f1o J, Romero Moya D, Richaud Patin Y, Giorgetti A. Generation of two heterozygous GATA2 CRISPR\/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency<\/strong>. Stem Cell Res. 2021;55102445-102445. doi:10.1016\/j.scr.2021.102445. IF:2,02.<\/p>\n– Maroni G, Bassal MA, Krishnan I, Fhu CW, Savova V, Zilionis R, Maymi VA, Pandell N, Csizmadia E, Zhang JY, Storti B, Castano J, Panella R, Li J, Gustafson CE, Fox S, Levy RD, Meyerovitz CV, Tramontozzi PJ, Vermilya K, De Rienzo A, Crucitta S, Basseres DS, Weetall M, Branstrom A, Giorgetti A, Ciampi R, Del Re M, Danesi R, Bizzarri R, Yang H, Kocher O, Klein AM, Welner RS, Bueno R, Magli MC, Clohessy JG, Ali A, Tenen DG, Levantini E. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer<\/strong>. Commun Biol. 2021;4(1):370-370. doi:10.1038\/s42003-021-01897-6. IF:6,27.<\/p>\n\t\t\t\t\tProyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t20DPS001. Human disease modelling of GATA2-related Myelodysplastic Syndromes and Acute Myeloid Leukemia<\/strong>. Generalitat de Catalunya- Departament de Salut. Budget: 208600. 2019-2023. PI: Giorgetti, Alessandra.<\/p>\n21MAR001. New approaches for the identification and functional characterization of prognostic genetic biomarkers in inherited childhood myelodysplastic\/acute leukemia syndromes.<\/strong> MARATO TV3. Budget: 146000. 2021-2024. PI: Giorgetti, Alessandra.<\/p>\nINT21042. Die Untersuchung genetischer und mechanistischer Auswirkungen einer Monosomie 7 bei der GATA2 Defizienz (Investigating genetic and mechanistic contributions of monosomy 7 in GATA2 deficiency)<\/strong>. DEUTSCHE JOS\u00c9 CARRERAS LEUK\u00c4MIE-STIFTUNG E.V.. Budget: 130100. 2022-2024. PI: Giorgetti, Alessandra.<\/p>\nMCI21006. Tracking leukemic transformation of GATA2 deficiency using omics and human stem cell-based models.<\/strong> MINECO. Budget: 121000. 2021-2024. PI: Giorgetti, Alessandra.<\/p>\n21CEE006. Single cell tracking of malignant transformation in GATA2 deficiency. MSCA.<\/strong> Budget: 120000. 2021-2023. PI: MARIN BEJAR, OSKAR.<\/p>\n\t\t\t\t![\"Alessandra-Giorgetti22\"](\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2022\/10\/Alessandra-Giorgetti22-150x150.jpg\" "\\"Alessandra-Giorgetti22\\"")
\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\n\t\tENLACES RELACIONADOS\n\t<\/h4>\n\n\t\t\n\t\t@HeSteCBio\n\t\t<\/a>\n\t<\/h4>\n\n\t\t\n\t\tORCID\n\t\t<\/a>\n\t<\/h4>\n\n\t\t\n\t\tGoogle Scholar\n\t\t<\/a>\n\t<\/h4>\n\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tJefa de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as postdoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as predoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\tJefa de grupo\n\t\t\t\t\t\t\t\t\t\t\t\n- Giorgetti, Alessandra<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadores\/as postdoctorales\n\t\t\t\t\t\t\t\t\t\t\t
\n- Romero Moya, Dami\u00e0<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadores\/as predoctorales\n\t\t\t\t\t\t\t\t\t\t\t
\n- Pera Garcia, Joan<\/li>\n
- Magallon Mosella, Maria<\/li>\n<\/ul>\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn nuevo estudio identifica una firma epigen\u00e9tica asociada a la deficiencia de GATA2, un trastorno gen\u00e9tico raro<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/03\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tComienza el programa de intercambio entre el IDIBELL y el SZBL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl grupo liderado por la Dra. Alessandra Giorgetti recibe una ayuda de la GESMD para estudiar el s\u00edndrome mielodispl\u00e1sico<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t18\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa Marat\u00f3 financiar\u00e1 con 1,5 millones de euros 10 proyectos del IDIBELL en enfermedades minoritarias<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/11\/2020\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"Biolog\u00eda de c\u00e9lulas madre hematopoy\u00e9ticas y leucemog\u00e9nesis Resumen Las c\u00e9lulas madre hematopoy\u00e9ticas (HSC) se consideran la base de la hematopoyesis en adultos. Actualmente, la mayor\u00eda de estos trastornos hematol\u00f3gicos son curables mediante trasplante de HSC. Sin embargo, la disponibilidad limitada de donantes compatibles \u00f3ptimos sigue siendo un desaf\u00edo, especialmente para individuos de origen no cauc\u00e1sico […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":3588,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-11 13:41:19","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/13392"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=13392"}],"version-history":[{"count":5,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/13392\/revisions"}],"predecessor-version":[{"id":23652,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/13392\/revisions\/23652"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3588"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=13392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\t\t\t\t\tL\u00edneas estrat\u00e9gicas<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tIdentificar v\u00edas de desarrollo involucradas en la generaci\u00f3n de c\u00e9lulas madre hematopoy\u00e9ticas para dirigir la diferenciaci\u00f3n de c\u00e9lulas madre pluripotenciales en c\u00e9lulas hematopoy\u00e9ticas cl\u00ednicamente relevantes<\/p>\n
Desarrollar modelos de desarrollo de c\u00e9lulas madre del c\u00e1ncer de sangre basados \u200b\u200ben c\u00e9lulas pluripotentes inducidas.<\/p>\n
Estos objetivos se realizar\u00e1n combinando gen\u00f3mica, transcript\u00f3mica, edici\u00f3n de genes y t\u00e9cnicas biol\u00f3gicas celulares.<\/p>\n
<\/p>\n\t\t\t\t\tPublicaciones seleccionadas<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t – Bigas A, Palma LG, Kartha GM, Giorgetti A. Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development.<\/strong> Stem Cells Transl. Med. 2022. doi: 10.1093\/stcltm\/szac071<\/p>\n – Kotmayer L, Romero Moya D, Marin Bejar O, Kozyra E, Catal\u00e0 A, Bigas A, Wlodarski MW, B\u00f6d\u00f6r C, Giorgetti A. GATA2 deficiency and MDS\/AML: Experimental strategies for disease modelling and future therapeutic prospects.<\/strong> Br J Haematol. 2022;199(4):482-495. doi:10.1111\/bjh.18330.<\/p>\n – Pera J, Casta\u00f1o J, Casamitjana J, Giorgetti A, Romero Moya D. Generation of heterozygous SAMD9 CRISPR\/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation<\/strong>. Stem Cell Res. 2022;64102906-102906. doi:10.1016\/j.scr.2022.102906. IF:1,59.<\/p>\n – Casta\u00f1o J, Romero Moya D, Richaud Patin Y, Giorgetti A. Generation of two heterozygous GATA2 CRISPR\/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency<\/strong>. Stem Cell Res. 2021;55102445-102445. doi:10.1016\/j.scr.2021.102445. IF:2,02.<\/p>\n – Maroni G, Bassal MA, Krishnan I, Fhu CW, Savova V, Zilionis R, Maymi VA, Pandell N, Csizmadia E, Zhang JY, Storti B, Castano J, Panella R, Li J, Gustafson CE, Fox S, Levy RD, Meyerovitz CV, Tramontozzi PJ, Vermilya K, De Rienzo A, Crucitta S, Basseres DS, Weetall M, Branstrom A, Giorgetti A, Ciampi R, Del Re M, Danesi R, Bizzarri R, Yang H, Kocher O, Klein AM, Welner RS, Bueno R, Magli MC, Clohessy JG, Ali A, Tenen DG, Levantini E. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer<\/strong>. Commun Biol. 2021;4(1):370-370. doi:10.1038\/s42003-021-01897-6. IF:6,27.<\/p>\n\t\t\t\t\tProyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t 20DPS001. Human disease modelling of GATA2-related Myelodysplastic Syndromes and Acute Myeloid Leukemia<\/strong>. Generalitat de Catalunya- Departament de Salut. Budget: 208600. 2019-2023. PI: Giorgetti, Alessandra.<\/p>\n 21MAR001. New approaches for the identification and functional characterization of prognostic genetic biomarkers in inherited childhood myelodysplastic\/acute leukemia syndromes.<\/strong> MARATO TV3. Budget: 146000. 2021-2024. PI: Giorgetti, Alessandra.<\/p>\n INT21042. Die Untersuchung genetischer und mechanistischer Auswirkungen einer Monosomie 7 bei der GATA2 Defizienz (Investigating genetic and mechanistic contributions of monosomy 7 in GATA2 deficiency)<\/strong>. DEUTSCHE JOS\u00c9 CARRERAS LEUK\u00c4MIE-STIFTUNG E.V.. Budget: 130100. 2022-2024. PI: Giorgetti, Alessandra.<\/p>\n MCI21006. Tracking leukemic transformation of GATA2 deficiency using omics and human stem cell-based models.<\/strong> MINECO. Budget: 121000. 2021-2024. PI: Giorgetti, Alessandra.<\/p>\n 21CEE006. Single cell tracking of malignant transformation in GATA2 deficiency. MSCA.<\/strong> Budget: 120000. 2021-2023. PI: MARIN BEJAR, OSKAR.<\/p>\n\t\t\t\t Biolog\u00eda de c\u00e9lulas madre hematopoy\u00e9ticas y leucemog\u00e9nesis Resumen Las c\u00e9lulas madre hematopoy\u00e9ticas (HSC) se consideran la base de la hematopoyesis en adultos. Actualmente, la mayor\u00eda de estos trastornos hematol\u00f3gicos son curables mediante trasplante de HSC. Sin embargo, la disponibilidad limitada de donantes compatibles \u00f3ptimos sigue siendo un desaf\u00edo, especialmente para individuos de origen no cauc\u00e1sico […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":3588,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-11 13:41:19","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/13392"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=13392"}],"version-history":[{"count":5,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/13392\/revisions"}],"predecessor-version":[{"id":23652,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/13392\/revisions\/23652"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3588"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=13392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n
\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t
\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n
\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLACES RELACIONADOS\n\t<\/h4>\n
\n\t\t\n\t\t@HeSteCBio\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tORCID\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tGoogle Scholar\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tJefa de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as postdoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as predoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\tJefa de grupo\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn nuevo estudio identifica una firma epigen\u00e9tica asociada a la deficiencia de GATA2, un trastorno gen\u00e9tico raro<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/03\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tComienza el programa de intercambio entre el IDIBELL y el SZBL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl grupo liderado por la Dra. Alessandra Giorgetti recibe una ayuda de la GESMD para estudiar el s\u00edndrome mielodispl\u00e1sico<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t18\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa Marat\u00f3 financiar\u00e1 con 1,5 millones de euros 10 proyectos del IDIBELL en enfermedades minoritarias<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/11\/2020\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"